메뉴 건너뛰기




Volumn 54, Issue 52, 1998, Pages 15833-15844

New skeletal rearrangements of C and D rings of a 13-oxobaccatin III derivative

Author keywords

[No Author keywords available]

Indexed keywords

13 OXOBACCATIN III; 13 OXOBACCATIN III DERIVATIVE; 7,13 DIOXO SECOBACCATIN III; DOCETAXEL; PACLITAXEL; PACLITAXEL DERIVATIVE; TAXOID; UNCLASSIFIED DRUG;

EID: 0032564580     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(98)00993-4     Document Type: Article
Times cited : (9)

References (35)
  • 6
    • 0001843250 scopus 로고
    • Taxane anticancer agents: Basic science and current status
    • American Chemical Society, Washington D.C.
    • (b) Taxane Anticancer Agents: Basic Science and Current Status Georg, I.G.; Chen, T.T.; Ojima, I.; Vyas, D.M. Eds.; ACS Symposium Series No 583, American Chemical Society, Washington D.C. 1995;
    • (1995) ACS Symposium Series No 583 , vol.583
    • Georg, I.G.1    Chen, T.T.2    Ojima, I.3    Vyas, D.M.4
  • 8
    • 0001843250 scopus 로고
    • Paclitaxel structure-activity relationships and skeletal rearrangements
    • Georg, I.G.; Chen, T.T.; Ojima, I.; Vyas, D.M. Eds.; ACS Symposium Series No American Chemical Society, Washington D.C., and references therein
    • [5] (a) Chen, S.-H.; Farina, V. Paclitaxel Structure-Activity Relationships and Skeletal Rearrangements. InTaxane Anticancer Agents: Basic Science and Current Status Georg, I.G.; Chen, T.T.; Ojima, I.; Vyas, D.M. Eds.; ACS Symposium Series No 583, American Chemical Society, Washington D.C., 1995; pp 247-261 and references therein
    • (1995) Taxane Anticancer Agents: Basic Science and Current Status , vol.583 , pp. 247-261
    • Chen, S.-H.1    Farina, V.2
  • 9
    • 0013447222 scopus 로고
    • Paclitaxel (Taxol®) chemistry and structure-activity relationships
    • Farina V. Ed.; Elsevier, and references therein
    • (b) Chen, S.-H.; Farina, V. Paclitaxel (Taxol®) Chemistry and Structure-Activity Relationships. In The Chemistry and Pharmacology of Taxol® and its Derivatives Farina V. Ed.; Elsevier, 1995, pp 165-253 and references therein.
    • (1995) The Chemistry and Pharmacology of Taxol® and its Derivatives , pp. 165-253
    • Chen, S.-H.1    Farina, V.2
  • 23
    • 85038554429 scopus 로고    scopus 로고
    • 13-oxobaccatin III was first described in ref 1
    • [19] 13-oxobaccatin III was first described in ref 1.
  • 24
    • 0001843250 scopus 로고
    • Taxane anticancer agents: Basic science and current status
    • Georg, I.G.; Chen, T.T.; Ojima, I.; Vyas, D.M. Eds.; American Chemical Society, Washington D.C.
    • [20] Guéritte-Voegelein, F.; Guénard, D.; Dubois, J.; Wahl, A.; Marder, R.; Müller, R.; Lund, M.; Bricard, L.; Potier, P. in Taxane Anticancer Agents: Basic Science and Current Status Georg, I.G.; Chen, T.T.; Ojima, I.; Vyas, D.M. Eds.; ACS Symposium Series No 583, American Chemical Society, Washington D.C., 1995; pp 189-202
    • (1995) ACS Symposium Series No 583 , vol.583 , pp. 189-202
    • Guéritte-Voegelein, F.1    Guénard, D.2    Dubois, J.3    Wahl, A.4    Marder, R.5    Müller, R.6    Lund, M.7    Bricard, L.8    Potier, P.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.